Lu-177-Oxodotreotide (Lutathera®)
177Lu-Oxodotreotide (177Lu-Lutathera®, 177Lu-DOTATATE) is a radiolabeled somatostatin analogue developed [...]
177Lu-Oxodotreotide (177Lu-Lutathera®, 177Lu-DOTATATE) is a radiolabeled somatostatin analogue developed [...]
177Lu-EDTMP is the 177Lu equivalent of 153Sm-Lexidronam (153Sm-EDTM) developed for [...]
177Lu-DOTAZOL is a drug suitable for betatherapy of bone metastases [...]
177Lu-TLX591 (177Lu-Rosopatamab, 177Lu-J591, 177Lu-ATL-101) is the Lutetium-177 labeled J591 [...]
IART® stands for Intraoperative Avidination for Radionuclide Treatment. It is [...]
177Lu-PSMA-617 (177Lu-Vipivotide tetratexan) is a 177Lu labeled peptide developed [...]
177Lu-Pentixather is the therapeutic analogue of 68Ga-Pentixafor, to be used [...]
177Lu-IPN-1072 (177Lu-OPS201, 177Lu-DOTA-JR11, 177Lu-Satoreotide tetratexan) is the lutetium-177 analogue [...]
177Lu-MVT-1075 is the therapeutic counterpart of 89Zr-DFO-HuMab-5B1 developed for the [...]
177Lu-IPN-01087 (177Lu-3BP-227) is a neurotensin antagonist peptide labeled with 177Lu [...]